4th Circ. Revives Challenge To Generic Celebrex Exclusivity
The Fourth Circuit on Tuesday overturned a West Virginia federal judge's ruling that allowed Teva Pharmaceutical Industries Ltd. to keep exclusive rights to market its generic version of Pfizer Inc.'s arthritis...To view the full article, register now.
Already a subscriber? Click here to view full article